by Eric Christianson | Jul 30, 2017 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
In a previous post, I discussed the rare situation of patients being on both gabapentin and pregabalin and some possible explanations for this scenario. That prompted someone to ask me how to do a conversion of gabapentin to pregabalin. Let’s set up the...
by Eric Christianson | Jul 5, 2017 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
I can’t think of a good reason to use gabapentin and pregabalin together, but I have seen it a few times. Here’s the med list and what I would look at. Dulaglutide 0.5 mls once weekly Gabapentin 100 mg TID Omeprazole 20 mg BID Trazodone 100 mg HS...
by Eric Christianson | Jun 21, 2017 | Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls
Timing of ADHD medications is a bit of an art. ADHD medications are used to help children pay attention and ultimately perform better in school and for other activities. Use of these medications is definitely not without controversy. While I won’t address...
by Eric Christianson | May 28, 2017 | Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls
I came across this useful table of benzodiazepine equivalents and decided to share it with you. Converting one drug to another always comes with challenges and benzodiazepines are no different. It’s not always easy to know exactly what to do or how to convert...
by Eric Christianson | May 14, 2017 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Drug interactions is one thing that pharmacists need to be experts at managing. Gemfibrozil and statins present an interesting drug interaction that needs to be addressed. How should we address the interaction? Do other alternatives exist? Other alternatives to the...
by Eric Christianson | May 10, 2017 | Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls
When giving a presentation the other day, I received a question about how to handle gabapentin abuse. It is a tough question, much like opioid, benzo, stimulant, or any other controlled substance. Recognizing the risk of abuse potential, in August 2016, Minnesota...
